These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 19453526)

  • 1. Evaluation of pulmonary nodules and lung cancer with one-inch crystal gamma coincidence positron emission tomography/CT versus dedicated positron emission tomography/CT.
    Moodie K; Cherk MH; Lau E; Turlakow A; Skinner S; Hicks RJ; Kelly MJ; Kalff V
    J Med Imaging Radiat Oncol; 2009 Feb; 53(1):32-9. PubMed ID: 19453526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulomatous disease: is it a nuisance or an asset during PET/computed tomography evaluation of lung cancers?
    Chundru S; Wong CY; Wu D; Balon H; Palka J; Chang CY; Gaskill M; Cheng CY; Huang WS; Fink-Bennett D
    Nucl Med Commun; 2008 Jul; 29(7):623-7. PubMed ID: 18528184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
    Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K
    J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT.
    Orlacchio A; Schillaci O; Antonelli L; D'Urso S; Sergiacomi G; Nicolì P; Simonetti G
    Radiol Med; 2007 Mar; 112(2):157-73. PubMed ID: 17361379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
    Bar-Shalom R; Kagna O; Israel O; Guralnik L
    Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system.
    Strobel K; Rüdy M; Treyer V; Veit-Haibach P; Burger C; Hany TF
    Nucl Med Commun; 2007 Jul; 28(7):555-9. PubMed ID: 17538397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG.
    Tian J; Yang X; Yu L; Chen P; Xin J; Ma L; Feng H; Tan Y; Zhao Z; Wu W
    J Nucl Med; 2008 Feb; 49(2):186-94. PubMed ID: 18199618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
    Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
    Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance characteristics of a new 3-dimensional continuous-emission and spiral-transmission high-sensitivity and high-resolution PET camera evaluated with the NEMA NU 2-2001 standard.
    Matsumoto K; Kitamura K; Mizuta T; Tanaka K; Yamamoto S; Sakamoto S; Nakamoto Y; Amano M; Murase K; Senda M
    J Nucl Med; 2006 Jan; 47(1):83-90. PubMed ID: 16391191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of a breath-holding acquisition method in PET/CT for pulmonary lesions.
    Yamaguchi T; Ueda O; Hara H; Sakai H; Kida T; Suzuki K; Adachi S; Ishii K
    Ann Nucl Med; 2009 Jan; 23(1):65-71. PubMed ID: 19205840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study.
    Halpern BS; Dahlbom M; Auerbach MA; Schiepers C; Fueger BJ; Weber WA; Silverman DH; Ratib O; Czernin J
    J Nucl Med; 2005 Apr; 46(4):603-7. PubMed ID: 15809482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer.
    Sato M; Okumura T; Kaito K; Kiyoshima M; Asato Y; Uchiumi K; Iijima H; Hashimoto I; Kaburagi T; Amemiya R
    Ann Nucl Med; 2009 Jan; 23(1):49-57. PubMed ID: 19205838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pulmonary nodules: comparison of a prototype dual crystal (LSO/NAI) dual head coincidence camera and full ring positron emission tomography (PET).
    Joshi U; Raijmakers PG; van Lingen A; Comans EF; Pijpers R; Teule GJ; Hoekstra OS
    Eur J Radiol; 2005 Aug; 55(2):250-4. PubMed ID: 16036155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
    Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
    J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coincidence imaging using 2 dual-head gamma-camera systems, with and without attenuation correction.
    Even-Sapir E; Yuzefovich B; Miller E; Bouhnik JP; Zak O; Lerman H; Lievshitz G; Levin C
    J Nucl Med Technol; 2004 Dec; 32(4):190-7. PubMed ID: 15576340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of PET/CT in the characterization of solid or partly solid solitary pulmonary nodules.
    Jeong SY; Lee KS; Shin KM; Bae YA; Kim BT; Choe BK; Kim TS; Chung MJ
    Lung Cancer; 2008 Aug; 61(2):186-94. PubMed ID: 18280613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data.
    Martinez-Möller A; Souvatzoglou M; Delso G; Bundschuh RA; Chefd'hotel C; Ziegler SI; Navab N; Schwaiger M; Nekolla SG
    J Nucl Med; 2009 Apr; 50(4):520-6. PubMed ID: 19289430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT for the staging and follow-up of patients with malignancies.
    Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
    Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.
    Tuncel M; Souvatzoglou M; Herrmann K; Stollfuss J; Schuster T; Weirich G; Wester HJ; Schwaiger M; Krause BJ
    Nucl Med Biol; 2008 Aug; 35(6):689-95. PubMed ID: 18678354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-dimensional vs three-dimensional imaging in whole body oncologic PET/CT: a Discovery-STE phantom and patient study.
    Bettinardi V; Mancosu P; Danna M; Giovacchini G; Landoni C; Picchio M; Gilardi MC; Savi A; Castiglioni I; Lecchi M; Fazio F
    Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):214-23. PubMed ID: 17464266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.